New York, December 28, 2023 – Enveric Biosciences (NASDAQ: ENVB), a biotechnology company specializing in developing novel treatments for mental health disorders, has named EB-003 as the lead candidate from its EVM301 Series. This series targets depression, anxiety, and addiction disorders. The selection of EB-003 is a key milestone for Enveric, transitioning the company from a discovery phase to … Continue reading “Enveric Biosciences Announces EB-003 as Lead Drug Candidate for Mental Health Disorders; Stock Jumps 37%”
Author: Sophia Vida
SinglePoint Successfully Lists on Cboe; Welcomes Tony Thomas as New Board Member in Expansion of Board Bolstering Company’s Commitment to Strategic Growth in the Solar Sector
Phoenix, AZ, December 28, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or “the Company”) a provider…
PRISM Emerging MedDevices Mover Spotlight: Milestone Scientific Inc. (MLSS)
New York, December 27, 2023 – Milestone Scientific Inc. (NYSE:MLSS) has established itself in the…
Immutep Advances Towards Phase III Trial for Lung Cancer Treatment with Positive Regulatory Feedback
New York, December 27, 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP), a trailblazing clinical-stage biotechnology company,…
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Acquires Parabola Mgmt., LLC
Acquisition Completes and Establishes Key Revenue Drivers COSTA MESA, CA, December 27, 2023 – Rodedawg…
SPZI: $53.4 million fully executed commodity contract closed
JP Energy Global, a wholly owned subsidiary of JP 3E Holdings, Inc., formerly Spooz Inc.,…
SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa
Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System…
PRISM MediaWire – Weekly Press Resume – Dec. 18 to Dec. 22, 2023
New York, December 22, 2023 PRISM MediaWire – Weekly Press Resume Dec. 18 to Dec.…
HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment
New York, December 22, 2023 – Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK),…
PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%
New York, December 22, 2023 – PetVivo Holdings, Inc. (Nasdaq: PETV) has achieved a distribution milestone, reporting…
PRISM Analysis: Why Did CareCloud Shares Jump This Week?
New York, December 22, 2023 – Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump…
Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start
New York, December 21, 2023 – In two weeks, 2023 will be history so consider…
Palatin Technologies Sells Vyleesi in $171M Transaction
New York, December 21, 2023 – Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to…
SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange
Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30…
